NasdaqCM - Nasdaq Real Time Price USD
XTL Biopharmaceuticals Ltd. (XTLB)
1.2684
-0.0416
(-3.18%)
As of 11:18:12 AM EDT. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
2,426
4,186
6,618
6,503
Total Liabilities Net Minority Interest
206
187
1,285
2,891
Total Equity Gross Minority Interest
2,220
3,999
5,333
3,612
Total Capitalization
2,220
3,999
5,333
3,612
Common Stock Equity
2,220
3,999
5,333
3,612
Net Tangible Assets
1,840
3,619
4,953
3,232
Working Capital
1,840
3,619
6,006
5,867
Invested Capital
2,220
3,999
5,333
3,612
Tangible Book Value
1,840
3,619
4,953
3,232
Share Issued
544,906.1490
544,906.1490
544,906.1490
514,205.7990
Ordinary Shares Number
544,906.1490
544,906.1490
544,906.1490
514,205.7990
12/31/2020 - 9/1/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
NXOA.BE Nicox SA
0.2260
0.00%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%
GON.DU Geron Corp
1.2350
+0.90%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%
OCD1.MU ChromaDex Corp
6.20
+3.33%
GNRO.PA GeNeuro SA
0.0700
-10.26%